Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in Insomnia

JULY 20, 2015
Jennifer A. Reinhold, PharmD, BCPS, BCPP
This activity is supported by an educational grant from Merck Sharp & Dohme Corp.


Wake-Up Call: Engaging the Pharmacist in Individualizing Treatment and Optimizing Patient Outcomes in Insomnia
 

Faculty
Jennifer A. Reinhold, PharmD, BCPS, BCPP
Associate Professor of Clinical Pharmacy
Department of Pharmacy Practice/
Pharmacy Administration
Philadelphia College of Pharmacy
University of the Sciences in Philadelphia
Philadelphia, Pennsylvania
 
Educational Objectives
After completing this continuing education program, the participant will be able to:
  • Outline the prevalence, pathophysiology, and consequences of insomnia.
  • Review patient-specific and drug specific factors in making therapeutic decisions.
  • Study the efficacy, safety, and differentiating characteristics of currently available treatment options for insomnia, particularly the newer-generation nonbenzodiazepines.
  • Discuss the pharmacist’s role in assisting physicians in individualizing treatment and educating patients about insomnia, as well as nonprescription and prescription treatments.
 
Target audience: Pharmacists
Type of activity: Knowledge
Release date: July 6, 2015
Expiration date: July 6, 2016
Estimated time to complete activity: 2.0 hours
Fee: Free

Pharmacy Times Office of Continuing Professional Education is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 2.0 contact hours (0.2 CEUs) under the ACPE universal activity number 0290-0000-15-067-H01-P. The activity is available for CE credit through July 6, 2016.

SHARE THIS
0